We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
- Authors
Falcone, Alfredo; Ricci, Sergio; Brunetti, Isa; Pfanner, Elisabetta; Allegrini, Giacomo; Barbara, Cecilia; Crinò, Lucio; Benedetti, Giovanni; Evangelista, Walter; Fanchini, Laura; Cortesi, Enrico; Picone, Vincenzo; Vitello, Stefano; Chiara, Silvana; Granetto, Cristina; Porcile, Gianfranco; Fioretto, Luisa; Orlandini, Cinzia; Andreuccetti, Michele; Masi, Gianluca; Gruppo Oncologico Nord Ovest
- Abstract
The Gruppo Oncologico Nord Ovest (GONO) conducted a phase III study comparing fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI [irinotecan 165 mg/m2 day 1, oxaliplatin 85 mg/m2 day 1, leucovorin 200 mg/m2 day 1, fluorouracil 3,200 mg/m2 48-hour continuous infusion starting on day 1, every 2 weeks]) with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 13, p1670
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.09.0928